Your browser doesn't support javascript.
loading
Regression of BRAF V600E mutant adult glioblastoma after primary combined BRAF-MEK inhibitor targeted therapy: a report of two cases.
Woo, Peter Y M; Lam, Tai-Chung; Pu, Jenny K S; Li, Lai-Fung; Leung, Roland C Y; Ho, Jason M K; Zhung, James T F; Wong, Belinda; Chan, Timonthy S K; Loong, Herbert H F; Ng, Ho-Keung.
Afiliação
  • Woo PYM; Department of Neurosurgery, Kwong Wah Hospital, Hong Kong.
  • Lam TC; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.
  • Pu JKS; Department of Neurosurgery, Queen Mary Hospital, Hong Kong.
  • Li LF; Department of Neurosurgery, Queen Mary Hospital, Hong Kong.
  • Leung RCY; Department of Medicine, Queen Mary Hospital, Hong Kong.
  • Ho JMK; Department of Neurosurgery, Kwong Wah Hospital, Hong Kong.
  • Zhung JTF; Department of Neurosurgery, Kwong Wah Hospital, Hong Kong.
  • Wong B; Pharmacy and Medical Therapeutics, Kwong Wah Hospital, Hong Kong.
  • Chan TSK; Department of Pathology, Kwong Wah Hospital, Hong Kong.
  • Loong HHF; Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong.
  • Ng HK; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong.
Oncotarget ; 10(38): 3818-3826, 2019 Jun 04.
Article em En | MEDLINE | ID: mdl-31217909
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Hong Kong
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Hong Kong